Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-29 @ 10:42 AM
Study NCT ID:
NCT00764634
Status:
COMPLETED
Last Update Posted:
2011-12-02
First Post:
2008-09-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
Sponsor:
DynPort Vaccine Company LLC, A GDIT Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09
Start Date Type:
None
Primary Completion Date:
2010-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-30
First Submit QC Date:
None
Study First Post Date:
2008-10-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-07-01
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2011-11-28
Last Update Post Date:
2011-12-02
Last Update Post Date Type:
ESTIMATED